Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0S0SE
|
|||
Former ID |
DIB016464
|
|||
Drug Name |
Rupintrivir
|
|||
Synonyms |
AG-7088; AG-7185
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Virus infection [ICD-11: 1A24-1D9Z] | Phase 2 | [1] | |
Company |
Pfizer
|
|||
Structure |
Download2D MOL |
|||
Formula |
C31H39FN4O7
|
|||
Canonical SMILES |
CCOC(=O)C=CC(CC1CCNC1=O)NC(=O)C(CC2=CC=C(C=C2)F)CC(=O)C(C(C)C)NC(=O)C3=NOC(=C3)C
|
|||
InChI |
1S/C31H39FN4O7/c1-5-42-27(38)11-10-24(16-21-12-13-33-29(21)39)34-30(40)22(15-20-6-8-23(32)9-7-20)17-26(37)28(18(2)3)35-31(41)25-14-19(4)43-36-25/h6-11,14,18,21-22,24,28H,5,12-13,15-17H2,1-4H3,(H,33,39)(H,34,40)(H,35,41)/b11-10+/t21-,22+,24+,28-/m0/s1
|
|||
InChIKey |
CAYJBRBGZBCZKO-BHGBQCOSSA-N
|
|||
CAS Number |
CAS 223537-30-2
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Rhinovirus Protease 3C (HRV P3C) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | In Vitro Resistance Study of Rupintrivir, a Novel Inhibitor of Human Rhinovirus 3C Protease . Antimicrob Agents Chemother. 2007 December; 51(12): 4366-4373. | |||
REF 2 | Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. J Virol. 2011 Oct;85(19):10319-31. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.